PMLive4m
Novo Nordisk and Gensaic enter cardiometabolic disease partnership worth $354m
Novo Nordisk and Gensaic have entered into a partnership worth up to $354m to develop new therapies for cardiometabolic ...
PMLive6m
Eli Lilly’s Jaypirca recommended by CHMP to treat chronic lymphocytic leukaemia
Eli Lilly’s Jaypirca (pirtobrutinib) has been recommended by the European Medicines Agency’s (EMA) human medicines committee ...
PMLive8m
Regeneron receives positive CHMP opinion for linvoseltamab in multiple myeloma
Regeneron Pharmaceuticals has received a positive opinion from the European Medicines Agency’s human medicines committee for ...
PMLive10m
Healthcare communications
The Healthcare Communications Association has recently revitalised its long-established efforts to evaluate impact (those of ...